Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 2
1962 1
1965 1
1966 1
1967 1
1968 1
1969 1
1972 1
1973 1
1974 1
1975 1
1976 2
1983 2
1984 2
1986 3
1987 1
1988 3
1989 1
1991 2
1994 1
1995 2
1996 3
1997 6
1998 6
1999 6
2000 4
2001 7
2002 2
2003 4
2004 6
2005 2
2006 5
2007 17
2008 17
2009 4
2010 12
2011 17
2012 9
2013 13
2014 13
2015 20
2016 17
2017 22
2018 15
2019 17
2020 14
2021 10
2022 21
2023 23
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
Hause AM, Moro PL, Baggs J, Zhang B, Marquez P, Melgar M, Britton A, Stroud E, Myers TR, Rakickas J, Blanc PG, Welsh K, Broder KR, Su JR, Shay DK. Hause AM, et al. Among authors: britton a. MMWR Morb Mortal Wkly Rep. 2024 May 30;73(21):489-494. doi: 10.15585/mmwr.mm7321a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38814851 Free PMC article. No abstract available.
Radiation Reveal: Moving from research engagement to involvement.
Whittaker L, Dean JA, Veiga C, Langdon S, Drake R, Taylor D, Williams MC, Masters H, Britton A, Cumbo M, Burdis N, Mason K, Fay G, Smith E, Benson S, Halil A, Lambert S, Gaze MN, Gains J, Spencer B, Taylor-Gee A, Terry SYA. Whittaker L, et al. Among authors: britton a. Br J Cancer. 2024 Jun;130(10):1593-1598. doi: 10.1038/s41416-024-02648-0. Epub 2024 Apr 13. Br J Cancer. 2024. PMID: 38615107 Free PMC article. Review.
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
Romine JK, Li H, Coughlin MM, Jones JM, Britton A, Tyner HL, Fuller SB, Bloodworth R, Edwards LJ, Etoule JN, Morrill TC, Newes-Adeyi G, Olsho LEW, Gaglani M, Fowlkes A, Hollister J, Bedrick EJ, Uhrlaub JL, Beitel S, Sprissler RS, Lyski Z, Porter CJ, Rivers P, Lutrick K, Caban-Martinez AJ, Yoon SK, Phillips AL, Naleway AL, Burgess JL, Ellingson KD. Romine JK, et al. Among authors: britton a. Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093/cid/ciae130. Online ahead of print. Clin Infect Dis. 2024. PMID: 38466720
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Steinhardt L, Tyner H, Vandermeer M, Vaughan M, Yoon SK, Gaglani M, Naleway AL. Feldstein LR, et al. Among authors: britton a. JAMA. 2024 Feb 6;331(5):408-416. doi: 10.1001/jama.2023.27022. JAMA. 2024. PMID: 38319331
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Rivers P, Porter C, LeClair LB, Jeddy Z, Fowlkes AL, Lamberte JM, Herder K, Smith M, Rai R, Grant L, Hegmann KT, Jovel K, Vaughan M, Mathenge C, Phillips AL, Khan S, Britton A, Pilishvili T, Burgess JL, Newes-Adeyi G, Gaglani M, Caban-Martinez A, Yoon S, Lutrick K; PROTECT network. Rivers P, et al. Among authors: britton a. Vaccine. 2024 Mar 7;42(7):1512-1520. doi: 10.1016/j.vaccine.2024.01.016. Epub 2024 Feb 2. Vaccine. 2024. PMID: 38307743 Free article.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, Paden CR, Shirk P, Britton A, Smith ZR, Fleming-Dutra KE. Link-Gelles R, et al. Among authors: britton a. MMWR Morb Mortal Wkly Rep. 2024 Feb 1;73(4):77-83. doi: 10.15585/mmwr.mm7304a2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38300853 Free PMC article.
326 results